Fig. 1From: The influence of dietary peptide inhibitors of angiotensin-converting enzyme on the hypotensive effects of enalaprilSystolic blood pressure changes in SHR after single oral administration. Systolic blood pressure changes in SHR after single oral administration of (a) enalapril (3.0 mg/kg, ■), FMP (VPP, IPP: 3.5 mg/kg, ▲), or concomitant enalapril (3.0 mg/kg) and FMP (VPP, IPP: 3.5 mg/kg, ●); (b) enalapril (3.0 mg/kg, ■), FMP (VPP, IPP: 1.75 mg/kg, ▲), or concomitant enalapril (3.0 mg/kg) and FMP (VPP, IPP: 1.75 mg/kg, ●); (c) enalapril (3.0 mg/kg, ■), FPP (LKPNM: 10 mg/kg, ▲), or concomitant enalapril (3.0 mg/kg) and FPP (LKPNM: 10 mg/kg, ●). The control group (◆) received distilled water. Values are presented as the mean ± SE (n = 4). *p < 0.05 vs enalapril monotherapy group; ✢p < 0.05; ✢✢p < 0.01 vs the control group at the same time point (Bonferroni/Dunn, Scheffe’s F test)Back to article page